Tempus Announces the National Launch of FDA-Approved xT CDx Test
Go back to Tempus Announces the National Launch of FDA-Approved xT CDx Test| StemCells, Inc. (NASDAQ: TEM) | Delayed: 58.95 +0.21 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.74 | 52 Week High | $0.45 | |||
| Open | $59.47 | 52 Week Low | $0.37 | |||
| Day High | $59.75 | P/E | N/A | |||
| Day Low | $58.48 | EPS | $-0.31 | |||
| Volume | 803,179 | |||||
